2025-07-05 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA) based on the data you provided.  The report is structured to first present the key numbers, followed by a concise analysis.

**Report: Natera Inc. (NTRA) Analysis**

**Company Overview:** Natera Inc. is a genetic testing company focusing on reproductive health, oncology, and organ health.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (NTRA):** 126.91%
*   **Cumulative Return (VOO):** 96.44%
*   **Absolute Difference:** 33.3
*   **Relative Difference:** 10.8 (on a scale relative to the historical spread between NTRA and VOO)

**Analysis:** NTRA has outperformed the S&P 500, with a substantial cumulative return difference. However, the relative difference of 10.8 suggests that while NTRA is currently outperforming, it's near the lower end of its historical outperformance range against the S&P 500.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD   | Alpha    | Beta | Cap(B) |
|------------|---------|-------|----------|------|--------|
| 2015-2017  | -6.0%   | 62.4% | -31.0%   | 0.0  | 1.2    |
| 2016-2018  | 29.0%   | 80.1% | 11.0%    | 0.0  | 1.9    |
| 2017-2019  | 159.0%  | 80.1% | 130.0%   | 1.2  | 4.6    |
| 2018-2020  | 530.0%  | 80.1% | 510.0%   | 0.3  | 13.6   |
| 2019-2021  | 355.0%  | 62.9% | 307.0%   | 0.2  | 12.8   |
| 2020-2022  | -119.0% | 62.9% | -121.0%  | 0.2  | 5.5    |
| 2021-2023  | -482.0% | 69.9% | -500.0%  | 1.1  | 8.6    |
| 2022-2024  | -75.0%  | 70.6% | -100.0%  | 1.2  | 21.6   |
| 2023-2025  | 76.0%   | 72.8% | 28.0%    | 0.8  | 22.1   |

**Analysis:**

*   **CAGR & MDD:** The table shows significant volatility in Natera's performance over different periods. High CAGRs in some periods are offset by substantial MDDs (Maximum Drawdowns).
*   **Alpha:**  The Alpha figures highlight periods of significant outperformance (positive Alpha) and underperformance (negative Alpha) relative to the benchmark. Recent years show negative alpha, indicating underperformance.
*   **Beta:** Beta values fluctuate.  The company's market sensitivity has changed over time.
*   **Market Cap:** Market cap has significantly increased over the years.

**2. Recent Price Action**

*   **Current Price:** $161.76
*   **Previous Close:** $161.57
*   **Price Change:** $0.12
*   **5-day Moving Average:** $164.276
*   **20-day Moving Average:** $166.486
*   **60-day Moving Average:** $157.5248

**Analysis:**  The stock price is slightly up from the previous close, but below the 5-day and 20-day moving averages, suggesting a short-term downward trend. The price is above the 60-day moving average, indicating a potentially stronger longer-term trend. The small price change from the previous close indicates no immediate significant price action.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 46.25
*   **PPO:** -0.8044
*   **Hybrid Signal:** Cash_70%_Sell 0.2% of holdings (1 shares - Caution - MRI:0.33)
*   **20-day Relative Difference Change:** -1.3 (Negative - Short-term decline)
*   **Expected Return:** 163.0% (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:** The low MRI suggests relatively low market risk at this time.
*   **RSI:** The RSI of 46.25 is neutral, not indicating overbought or oversold conditions.
*   **PPO:** The negative PPO suggests that short-term price momentum is weaker than longer-term momentum.
*   **Hybrid Signal:** The hybrid signal suggests caution, recommending a high cash position and selling a small portion of holdings.
*   **Delta Relative Difference:** The recent negative change in relative difference confirms a short-term decline in the stock's performance compared to the S&P 500.
*   **Expected Return:** The high expected return indicates substantial potential outperformance relative to the S&P 500 over a long-term investment horizon (2+ years).

**4. Recent News & Significant Events**

*   **2025-07-03:** Major business developments, regulatory changes, or market events.
*   **2025-07-01:** Analyst discussions on performance and outlook.
*   **2025-07-02:** Stock volatility influenced by recent news, earnings, or executive actions.
*   **2025-07-05:** Market experts highlighting risks and opportunities, advising monitoring of news and announcements.

**Analysis:** The news snippets suggest that the stock is currently subject to volatility and is being actively monitored by analysts and market experts due to recent events. These events require further investigation to understand their impact on the company.

**5. Recent Earnings Analysis**

| Date       | EPS   | Revenue        |
|------------|-------|----------------|
| 2025-05-09 | -0.5  | 0.50 B$        |
| 2024-11-12 | -0.26 | 0.44 B$        |
| 2024-08-09 | -0.3  | 0.41 B$        |
| 2024-05-10 | -0.56 | 0.37 B$        |
| 2025-05-09 | -0.56 | 0.37 B$        |

**Analysis:** The company is not yet profitable, as indicated by the negative EPS values. While revenue has generally been increasing, it stalled in the most recent period.

**6. Financial Information:**

Revenue and Profitability:

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $0.50B   | 63.12%        |
| 2024-12-31 | $0.48B   | 62.94%        |
| 2024-09-30 | $0.44B   | 61.79%        |
| 2024-06-30 | $0.41B   | 58.83%        |
| 2024-03-31 | $0.37B   | 56.72%        |

Capital and Profitability:

| Quarter    | Equity   | ROE     |
|------------|----------|---------|
| 2025-03-31 | $1.24B   | -5.40%  |
| 2024-12-31 | $1.20B   | -4.50%  |
| 2024-09-30 | $0.88B   | -3.60%  |
| 2024-06-30 | $0.84B   | -4.48%  |
| 2024-03-31 | $0.79B   | -8.51%  |

**Analysis:**

*   **Revenue and Profit Margin:** Revenue has been consistently growing. Profit Margins are also increasing, which is a positive trend.
*   **Capital and Profitability:** Equity has increased significantly. However, the Return on Equity (ROE) is negative, indicating that the company is not generating profits from its equity.

**7. Overall Analysis**

Natera Inc. presents a mixed picture:

*   **Strengths:** Strong historical outperformance against the S&P 500, high revenue growth, improving profit margins, increasing equity, and a potentially very high long-term expected return (relative to the S&P 500).
*   **Weaknesses:** The company is currently unprofitable, evidenced by negative EPS and ROE. Recent performance has been weaker than in the past, and there are concerns of short-term decline. There are news events causing volatility.
*   **Overall:** NTRA appears to be a high-risk, high-reward investment. The long-term potential is significant, but the company faces profitability challenges. The recent news and short-term trends suggest caution is warranted. Investors should carefully monitor news, earnings releases, and market conditions. The 'Hybrid Signal' recommendation to hold a high cash position reflects this caution.

